Changes in company's own shares
Alvotech (ALVO) filed a notification with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) on 29 Dec 2025 regarding changes in the company's own shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Alvotech (ALVO) filed a notification with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) on 29 Dec 2025 regarding changes in the company's own shares. An attachment titled Alvotech Own Shares Notification 29 Dec 2025 was submitted with the filing. Investors should review the attached notification for the specific details and scope of the share changes.
Details
News Market Reaction – ALVO
On Dec 29, the day this news came out, ALVO closed 5.51% below the previous close.
Data tracked by StockTitan Argus for the Dec 29 session.
Key Figures
- CSSF filing date
- 29 Dec 2025
- Own-share notification filing attachment date
Historical Context
-
Publication of 2026 financial calendar and key reporting dates.
-
European launch of first-in-market Simponi biosimilar Gobivaz with Advanz.
-
Settlement granting AVT06 U.S. marketing start in Q4 2026, if approved.
-
USD 108M senior unsecured convertible bonds due 2030 in oversubscribed deal.
-
Launch of USD 100M convertible bond plus 2025/2026 revenue and EBITDA guidance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Attached is a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding changes in company's own shares.
Attachment
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.